Detalhe da pesquisa
1.
Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience.
J Med Virol
; 95(9): e29082, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671852